Dr. Jason Crowell talks with Dr. Karlo Lizarraga and Dr. Angela Hewitt about neurophysiological biomarkers to optimize deep brain stimulation in movement disorders.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Dan Ackerman talks with Prof. Urs Fischer about the use of thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with acute ischemic stroke.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Gregg Day talks with Dr. Mark Dubbelman about determining clinical meaningfulness in dementia. Read the full article in Neurology.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Stacey Clardy talks with Dr. W. Oliver Tobin about histiocytic diseases affecting the CNS.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Scott Mintzer talks with Dr. Adithya Sivaraju about predicting outcomes among patients undergoing intracranial EEG. Read the full article in Neurology.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. B.J. Hicks talks with Dr. Prachi Mehndiratta about the differences in multiple risk factors between Black and White individuals with young-onset ischemic stroke. Read the full article in Neurology.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jeff Ratliff talks with Dr. Adrienne Boire about the disordance between perceptions and experience in patients undergoing lumbar puncture. Read the full article in Neurology: Clinical Practice.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Farrah Mateen talks with Dr. Nicoline Schiess about the WHO Brain Health Unit and the Intersectoral Global Action Plan for Epilepsy and Other Neurological Disorders. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jason Crowell talks with Dr. Lucilla Parnetti about the clinical application of α-synuclein seed amplification assays (SAAs) in the identification of Parkinson disease and other synucleinopathies. Read the full article in Neurology.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

The August 2022 replay of past episodes showcases recent interviews in the realm of Parkinson disease (PD), with topics ranging from initial clinical management to more advanced methodologies to optimize treatment. This episode features conversations with Dr. Anthony Lang, Dr. Meredith Bock, and Dr. Jan Rusz on dopamine-based therapies in early PD, factors associated with quality of life in PD, and new research on speech impairment subtypes in PD, respectively. The episode concludes with Dr. Michael Fox discussing brain networks and their role in cognitive decline after DBS surgery.